Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Boehringer Ingelheim
McKinsey
Dow
Moodys

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for CP1-1189

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug CP1-1189: Sponsors, patents, clinical trial progress

CP1-1189 is an investigational drug.

There have been 4 clinical trials for CP1-1189. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 1993.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, and Leukemia, Myelogenous, Chronic, BCR-ABL Positive. The leading clinical trial sponsors are EA Pharma Co., Ltd., University of Leipzig, and Sheba Medical Center.

Recent Clinical Trials for CP1-1189
TitleSponsorPhase
A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male SubjectsEA Pharma Co., Ltd.Early Phase 1
Nilotinib Pre and Post Allogeneic Stem Cell TransplantationSheba Medical CenterPhase 2
Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)University of LeipzigPhase 1/Phase 2

See all CP1-1189 clinical trials

Clinical Trial Summary for CP1-1189

Top disease conditions for CP1-1189
Top clinical trial sponsors for CP1-1189

See all CP1-1189 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Baxter
AstraZeneca
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.